
Home / All Categories / DMEPOS Modifiers / Modifier KS
Modifier KS
Glucose Monitor Supply for Non-Insulin-Treated Beneficiaries
Modifier KS identifies glucose monitoring equipment and supplies furnished to Medicare beneficiaries with diabetes who are not treated with insulin, supporting accurate DMEPOS billing.
On This Page
Related Modifiers
Insulin-Treated Beneficiary
Modifier CG
CGM Coverage Criteria
Modifier KF
Class III Device
What Is Modifier KS?
Modifier KS is a HCPCS Level II modifier used in Medicare DMEPOS billing to identify glucose monitoring equipment and related supplies furnished to beneficiaries with diabetes who are not being treated with insulin.
Medicare uses this modifier to distinguish non-insulin-treated beneficiaries from those receiving insulin therapy. This distinction is important because glucose monitoring coverage, supply quantities, and claim reporting requirements may depend on the beneficiary's treatment regimen.
Modifier KS applies to eligible home blood glucose monitors, diabetic testing supplies, continuous glucose monitoring (CGM) devices, and related supply allowances. Suppliers must append KS to applicable HCPCS codes when the beneficiary is not insulin-treated.
A beneficiary may qualify for certain glucose monitoring equipment even without insulin treatment. For example, Medicare may cover a CGM for an eligible beneficiary with a documented history of problematic hypoglycemia, provided the applicable coverage criteria are met.
Unlike Modifier KX, which identifies insulin-treated beneficiaries for glucose monitoring claims, KS identifies beneficiaries who are not receiving insulin treatment.
Important: Modifier KS identifies insulin treatment status. It does not independently establish medical necessity or guarantee Medicare coverage for glucose monitoring equipment.
Quick Reference
Modifier: KS
Meaning: Non-Insulin-Treated
Category: DMEPOS
Type: HCPCS Level II
Used For: Glucose Monitoring
Billing: Medicare DME
When to Use Modifier KS
Non-Insulin-Treated Diabetes
Report KS when the beneficiary has diabetes but is not being treated with insulin and the claim involves applicable glucose monitoring equipment or supplies.
Home Blood Glucose Monitors
Use KS with eligible home glucose monitoring equipment when the beneficiary is not insulin-treated.
Diabetic Testing Supplies
Append KS to applicable test strips, lancets, and other covered glucose monitoring supplies.
Continuous Glucose Monitors
Use KS with eligible CGM devices and supply allowances for non-insulin-treated beneficiaries who meet Medicare's applicable coverage requirements.
Oral Diabetes Medication
KS may apply when diabetes is managed with oral medications rather than insulin.
Diet-Controlled Diabetes
KS may also apply when a beneficiary manages diabetes without insulin or other diabetes medication, provided the equipment and supplies meet Medicare coverage requirements.
Important: The modifier identifies treatment status, not the type of diabetes. A beneficiary with type 1 or type 2 diabetes must be evaluated according to the actual treatment regimen.
When NOT to Use Modifier KS
Insulin-Treated Beneficiaries
Do not report KS when the beneficiary is receiving insulin treatment. Modifier KX generally applies to eligible glucose monitoring claims for insulin-treated beneficiaries.
Unrelated DMEPOS Equipment
Do not append KS to equipment or supplies unrelated to the glucose monitoring codes covered by the applicable policy.
Unsupported Diabetes Diagnosis
KS does not establish diabetes or replace documentation supporting the beneficiary's diagnosis and need for monitoring.
Uncovered CGM Equipment
Do not use KS to indicate that a CGM meets Medicare coverage requirements when the required clinical criteria are not satisfied.
Incorrect Treatment Status
Do not continue reporting KS without reassessing the beneficiary's treatment status when documentation indicates insulin therapy has begun.
Important: KS and KX should not be reported together to describe the same beneficiary's insulin treatment status on an applicable glucose monitoring claim.
Modifier KS vs KX
These modifiers identify different insulin treatment circumstances for Medicare glucose monitoring claims.
Modifier KS – Non-Insulin-Treated
Purpose: Identifies beneficiaries not receiving insulin treatment.
When Used: Eligible glucose monitoring equipment and supplies for non-insulin-treated beneficiaries.
Billing Focus: Treatment status and applicable DMEPOS coverage rules.
Modifier KX – Insulin-Treated
Purpose: Identifies insulin-treated beneficiaries for applicable glucose monitoring claims.
When Used: Eligible glucose monitoring equipment and supplies for beneficiaries receiving insulin.
Billing Focus: Insulin treatment status and applicable coverage requirements.
Key Difference: KS identifies beneficiaries who are not treated with insulin, while KX identifies beneficiaries receiving insulin treatment. Neither modifier independently establishes that all Medicare coverage requirements are met.
Billing Example
A Medicare beneficiary has type 2 diabetes managed with oral medication and requires home blood glucose monitoring.
The treating practitioner orders blood glucose test strips, and the supplier confirms that the beneficiary is not receiving insulin.
Example – Blood Glucose Test Strips
HCPCS Code: A4253
Supply: Blood Glucose Test Strips
Billing Unit: 50 Strips
Quantity Supplied: 100 Strips
Units Billed: 2
Insulin Treatment: No
Modifier: KS
Example Claim: A4253-KS | 2 Units
Modifier KS identifies the beneficiary as non-insulin-treated. Two billing units represent 100 test strips under the HCPCS descriptor.
The supplier must verify that the quantity supplied meets Medicare's applicable utilization and documentation requirements.
Important: This example assumes the beneficiary meets Medicare coverage requirements and the supplier has a valid order. Modifier KS does not authorize unlimited testing supplies.
Documentation Requirements
Documentation must establish the beneficiary's diabetes diagnosis, treatment regimen, and medical need for glucose monitoring equipment or supplies.
Standard Written Order
Maintain a valid order identifying the glucose monitoring equipment or supplies prescribed.
Diabetes Diagnosis
Retain clinical documentation establishing that the beneficiary has diabetes mellitus.
Insulin Treatment Status
Verify and document that the beneficiary is not currently receiving insulin treatment.
Monitoring Requirements
Document the prescribed testing frequency or monitoring regimen when required for the equipment and supplies.
Supply Quantities
Maintain records supporting the type and quantity of glucose monitoring supplies furnished.
CGM Coverage Documentation
For CGM claims, retain documentation supporting the applicable coverage pathway, including problematic hypoglycemia when relevant.
Continued Medical Necessity
Maintain documentation supporting ongoing use and continued coverage when required by Medicare.
Documentation Checklist
Valid equipment or supply order
Diabetes diagnosis documented
Non-insulin treatment status verified
Monitoring requirements supported
HCPCS code confirmed
Supply quantity documented
CGM coverage criteria reviewed, if applicable
Continued coverage requirements met
Medicare Glucose Monitoring Billing Rules
Medicare covers qualifying glucose monitoring equipment and supplies under the durable medical equipment benefit. Modifier selection and reimbursement depend on the equipment, treatment status, and applicable coverage requirements.
Required Insulin Status Modifier
Medicare requires KS or KX on applicable glucose monitoring equipment and supply claims. KS identifies non-insulin-treated beneficiaries, while KX identifies insulin-treated beneficiaries.
Home Glucose Monitoring Supplies
For standard home blood glucose monitoring, Medicare generally allows up to 100 test strips and 100 lancets every three months for beneficiaries who are not treated with insulin. Higher quantities require additional medical necessity documentation and must meet applicable coverage requirements.
Continuous Glucose Monitor Eligibility
Non-insulin-treated beneficiaries may qualify for Medicare CGM coverage when they meet the applicable criteria, including a documented history of problematic hypoglycemia.
CGM Coverage Modifier
Modifier CG is required on applicable CGM device and supply allowance claims when the relevant Medicare coverage criteria are satisfied. KS identifies non-insulin treatment status, while CG addresses the applicable CGM coverage requirements.
CGM Supply Allowances
HCPCS A4239 identifies the monthly supply allowance for a non-adjunctive CGM. Medicare permits billing up to three units of the applicable CGM supply allowance within a 90-day period, subject to the relevant billing rules.
Continued CGM Coverage
Medicare requires periodic follow-up documentation supporting continued CGM use and medical necessity. The treating practitioner must evaluate the beneficiary's adherence to the CGM regimen and diabetes treatment at the required intervals.
Treatment Changes
If a beneficiary begins insulin treatment, the supplier must reassess modifier selection for subsequent claims. KS should not continue to be reported when the beneficiary is insulin-treated.
Important: Modifier KS does not establish CGM eligibility, override utilization limits, or replace required Medicare coverage documentation.
Common Billing Errors & Denials
Omitting Modifier KS
Failing to append KS to an applicable glucose monitor or supply claim for a non-insulin-treated beneficiary does not meet Medicare's modifier reporting requirements and may result in a denial.
Reporting KX Instead of KS
Using KX for a beneficiary who is not receiving insulin incorrectly identifies the treatment regimen and may affect claim processing.
Reporting KS and KX Together
These modifiers represent different insulin treatment statuses. Reporting both on the same applicable claim line creates inconsistent information.
Exceeding Standard Supply Limits
Billing excessive quantities of test strips or lancets without documentation supporting increased testing needs may result in denied quantities or overpayment findings.
Assuming KS Establishes CGM Coverage
Modifier KS does not confirm that a beneficiary meets Medicare's CGM coverage criteria. Applicable claims must satisfy the coverage policy and include other required modifiers.
Missing CG Modifier
Omitting CG from a CGM claim when the modifier is required can result in incorrect reporting, even when KS correctly identifies the beneficiary's insulin treatment status.
Incorrect CGM Supply Billing
Billing CGM sensors or other components separately when they are included in the applicable monthly supply allowance may result in unbundling-related denials.
Outdated Treatment Documentation
Continuing to report KS after the beneficiary begins insulin treatment can result in inaccurate claims.
Insufficient Medical Necessity Documentation
Missing orders, unsupported testing frequency, or inadequate CGM coverage documentation may lead to claim denials or recoupment during medical review.
Frequently Asked Questions
Can a beneficiary who takes oral diabetes medication qualify for a CGM with Modifier KS?
Yes. Medicare may cover a CGM for a non-insulin-treated beneficiary with a documented history of problematic hypoglycemia when all applicable coverage requirements are met. Modifier KS identifies treatment status but does not independently establish eligibility.
Is Modifier KS required on every claim for diabetic testing supplies?
KS is required on the applicable glucose monitoring equipment and supply codes identified in Medicare's glucose monitor billing policy when the beneficiary is not insulin-treated. Suppliers should verify the HCPCS code and current Medicare reporting requirements before submitting the claim.
ModifierLookup
Your trusted source for CPT and HCPCS modifier explanations, billing guidance, and coding resources
Categories
© 2025. All rights reserved.
Modifiers
Guides
Resources
Trusted Information
Practical Guidance
Accurate, up-to-date, and compliance-focused modifier guidance
Real-world billing examples and coding insights
Built for Professionals
Designed for coders, billers, and healthcare teams
Billing Guidelines
NCCI Edits Guide
Medicare Guidelines
Privacy Policy
Terms & Conditions
Sitemap
